A single-center, retrospective, matched cohort study evaluating safety and effectiveness of apixaban versus warfarin in patients with severe renal impairment.
Phase of Trial: Phase IV
Latest Information Update: 06 Feb 2017
At a glance
- Drugs Apixaban (Primary) ; Warfarin
- Indications Blood coagulation disorders
- Focus Therapeutic Use
- 06 Feb 2017 New trial record
- 24 Jan 2017 Primary endpoint (Major bleeding) has not been met, as per an article published in the Pharmacotherapy.
- 24 Jan 2017 Results published in the Pharmacotherapy